Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 3865Motor Activity 228Neoplasms 202Prostatic Neoplasms 167Colorectal Neoplasms 146Lung Neoplasms 139Lymphedema 125Fatigue 104Ovarian Neoplasms 98Carcinoma, Intraductal, Noninfiltrating 94Colonic Neoplasms 86Breast Cancer Lymphedema 86Pain 81Breast Cancer Female 76Anxiety Disorders 76Uterine Cervical Neoplasms 73Depression 70Triple Negative Breast Neoplasms 66Breast Carcinoma In Situ 66Head and Neck Neoplasms 55Pain, Postoperative 54Obesity 54Neoplasm Metastasis 48Melanoma 42Endometrial Neoplasms 39Pancreatic Neoplasms 38Lymphoma 38Carcinoma, Non-Small-Cell Lung 34Sleep Initiation and Maintenance Disorders 33Sarcoma 33

Interventions

Antineoplastic Agents 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Early Hormone Receptor-positive Breast Cancer × Breast × Clear all
NCT04278469 2020-02-20

Clinical High and Genomic Low Hormone Receptor-positive Early Breast Cancer Patients With or Without Adjuvant Chemotherapy

Gencurix, Inc.

Phase NA Recruiting
194 enrolled
Breast

Early Hormone Receptor-positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡